Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Baquacil
2. Cosmocil
3. Lavasept
4. Phmb Polymer
5. Polihexanide Hydrochloride
6. Poly(hexamethylene Biguanide)
7. Poly(hexamethylenebiguanide) Hydrochloride
8. Poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl) Hydrochloride
9. Polyhexamethylen-biguanide
10. Polyhexamethylenbiguanid
11. Polyhexamethylenbiguanide
12. Polyhexamethylene Biguanide
13. Polyhexamethylene Biguanide Hydrochloride
14. Polyhexanide
15. Vantocil
16. Vantocil Ib Of Vantocil
1. Polyhexamethylene Biguanide
2. 28757-47-3
3. Polyhexanide
4. 1-(diaminomethylidene)-2-hexylguanidine
5. Lavasept
6. Vantocil
7. Polihexanide Hydrochloride
8. Purista
9. Microcare Mbg
10. Cosmocil Cq
11. N-hexylbiguanide
12. 1-hexylbiguanide
13. Schembl45011
14. Chembl2106939
15. Schembl20753163
16. Dtxsid40873856
17. N-hexylimidodicarbonimidic Diamide
18. Zinc4217340
19. Akos017531707
20. Ft-0700841
21. Q408205
22. 24717-31-5
Molecular Weight | 185.27 g/mol |
---|---|
Molecular Formula | C8H19N5 |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 6 |
Exact Mass | 185.16404563 g/mol |
Monoisotopic Mass | 185.16404563 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 181 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of Acanthamoeba keratitis
Disinfectants
Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley's Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)
D - Dermatologicals
D08 - Antiseptics and disinfectants
D08A - Antiseptics and disinfectants
D08AC - Biguanides and amidines
D08AC05 - Polihexanide
Market Place
ABOUT THIS PAGE
38
PharmaCompass offers a list of Polyhexanide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Polyhexanide manufacturer or Polyhexanide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Polyhexanide manufacturer or Polyhexanide supplier.
PharmaCompass also assists you with knowing the Polyhexanide API Price utilized in the formulation of products. Polyhexanide API Price is not always fixed or binding as the Polyhexanide Price is obtained through a variety of data sources. The Polyhexanide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lavasept manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lavasept, including repackagers and relabelers. The FDA regulates Lavasept manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lavasept API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lavasept manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lavasept supplier is an individual or a company that provides Lavasept active pharmaceutical ingredient (API) or Lavasept finished formulations upon request. The Lavasept suppliers may include Lavasept API manufacturers, exporters, distributors and traders.
click here to find a list of Lavasept suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lavasept DMF (Drug Master File) is a document detailing the whole manufacturing process of Lavasept active pharmaceutical ingredient (API) in detail. Different forms of Lavasept DMFs exist exist since differing nations have different regulations, such as Lavasept USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lavasept DMF submitted to regulatory agencies in the US is known as a USDMF. Lavasept USDMF includes data on Lavasept's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lavasept USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lavasept suppliers with USDMF on PharmaCompass.
Lavasept Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lavasept GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lavasept GMP manufacturer or Lavasept GMP API supplier for your needs.
A Lavasept CoA (Certificate of Analysis) is a formal document that attests to Lavasept's compliance with Lavasept specifications and serves as a tool for batch-level quality control.
Lavasept CoA mostly includes findings from lab analyses of a specific batch. For each Lavasept CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lavasept may be tested according to a variety of international standards, such as European Pharmacopoeia (Lavasept EP), Lavasept JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lavasept USP).